Mengxia Zhang

Papers

Total Citations

H-Index

About

Dr. Mengxia Zhang is a pioneering head and neck surgeon whose work centers on innovative, minimally invasive approaches to treating recurrent nasopharyngeal carcinoma (NPC), with a particular focus on retropharyngeal lymph node (RPLN) disease. Her landmark 2020 study, "Transoral Robotic Retropharyngeal Lymph Node Dissection in Nasopharyngeal Carcinoma With Retropharyngeal Lymph Node Recurrence," has garnered 18 citations and represents a paradigm shift in salvage therapy. Dr. Zhang demonstrated that transoral robotic surgery (TORS) can safely access the anatomically challenging retropharyngeal space, offering a viable alternative to reirradiation—which carries severe radiotoxicity—and to high-risk open surgical approaches. This work directly addresses a critical unmet need, as RPLN recurrence after primary treatment is common and difficult to manage. By proving the feasibility and safety of TORS for this indication, Dr. Zhang has expanded the surgical armamentarium for recurrent NPC, potentially improving both oncologic outcomes and quality of life for patients. Her contributions are particularly notable for their potential to reduce treatment-related morbidity, marking her as a rising leader in the field of robotic head and neck surgery.